Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07892586
NA

Low-Dose Norepinephrine With Conservative Fluid Therapy in Hepatobiliary Surgery

Sponsor: Assiut University

View on ClinicalTrials.gov

Summary

This prospective randomized controlled study aims to compare the effect of low-dose norepinephrine combined with conservative goal-directed fluid therapy versus conventional fluid therapy on postoperative pulmonary complications assessed by lung ultrasound score in patients undergoing major hepatobiliary surgery.

Official title: Effect of Low-Dose Norepinephrine With Conservative Goal-Directed Fluid Therapy on Postoperative Pulmonary Complications in Major Hepatobiliary Surgeries

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2026-10-20

Completion Date

2028-02-20

Last Updated

2026-10-23

Healthy Volunteers

No

Interventions

OTHER

Conventional Fluid Therapy

Standard perioperative fluid administration based on maintenance requirements, fasting deficit, and third-space losses at 6-8 mL/kg/h using crystalloid solutions.

DRUG

Low-Dose Norepinephrine

Continuous intravenous infusion of norepinephrine starting at 0.03-0.05 µg/kg/min, titrated according to hemodynamic parameters.

OTHER

Conservative Goal-Directed Fluid Therapy

Restricted third-space fluid replacement at 2 mL/kg/h guided by stroke volume variation or pulse pressure variation.